The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
yi ma ti ni zhi hong pi bing 1 li
Author(s): 
Pages: 566-568
Year: Issue:  9
Journal: Journal of Clinical Dermatology

Keyword:  伊马替尼红皮病;
Abstract: <正>伊马替尼(格列卫)是一种酪氨酸激酶选择性抑制药物,常被用来治疗慢性白血病、消化道间质瘤。伊马替尼引发的皮肤反应很常见,一般皮疹较轻,不影响继续服药。也有一些患者可以发生严重的药疹[1-2]。现报告1例消化道间质瘤患者使用伊马替尼治疗3个月后引起严重红皮病,并且皮疹严重程度与患者用药剂量相关。1病历摘要患者男,54岁。因全身红色斑疹伴瘙痒3个月,加
Related Articles
No related articles found